Prescription

MRD / Regn No.

: THBC\23-24\05981

Date

: 16/06/2026

Patient Name

: Seema Rodricks

Age & Gender

: 48 Yrs. / Female

Contact No.

: 7666920077

UHID

Ht / Wt / BMI

: 162 / 76.55 / 29.17

BP S / BP D

: 151 / 96

Allergies

: NONE

Referred By

Problem List	:	T2DM (22/Nov/2024) \|
Subjective	:	T2DM SINCE NOV-2024,DOS: 10.3.2025,BP AT HOME - 120 / 85 MM HG,STARTING SGLT2 INHIBITOR,NO RESIDUAL TUMOR HOWEVER IGF 1 / GH STILL ELEVATED,WIL WAIT UPTO 1 YR POST SX BEFORE CONSIDERING RT
Objective	:	15-JUN-2026 REPORTS,HBA1C-8.7%
Plan	:	NEEDS SOME MORE TIME TO BE MENTALLY READY FOR RT

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	TELMISARTAN 40 MG TELMA 40 MG	ORAL	1-0-0	ABF	3 MTHS

2	SHELCAL HD 500 MG	ORAL	0-1-0	AL	3 MTHS

3	DRISE 60,000 UNITS	ORAL	1/15 DAYS	ANYTIME OF DAY	3 MTHS

4	GIBTULIO S 25/100 MG	ORAL	1-0-0	BBF	3 MTHS

5	GLIZID M XR 60/500 MG	ORAL	0-0-1	BD	3 MNTHS

Refill : 0 / Substitution:

Education

: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.

Next Visit

: 16/Sep/2026

Tests Suggested For Next Visit

: FBS / PPBS > 10 DAYS OF STARTING NEW MEDS,HBA1C > 6 WEEKS OF NEW PRESCRIPTION - IF HBA1C < 8% - SAME MEDS,AFTER 3 MTHS - HBA1C / FBS / PPBS / SERUM GH / SERUM IGF1 / FREE T3 / FREE T4 / TSH / SERUM CORTISOL